MRP Gene Expression in Colorectal Carcinomas
Author Information
Author(s): M Filipits, RW Suchomell, G Dekan, W Stiglbauer, K Haider, D Depisch, R Pirker
Primary Institution: University of Vienna Medical School
Hypothesis
What is the clinical significance of MRP gene expression in colorectal carcinomas?
Conclusion
The MRP gene is expressed in primary colorectal carcinomas but does not correlate with known prognostic factors or patient survival.
Supporting Evidence
- MRP mRNA expression was observed in 88% of tumor specimens.
- Strong MRP staining was detected in 23% of samples.
- Overall survival of patients with strong MRP-staining tumors was similar to those with weak-staining tumors.
Takeaway
This study looked at a gene called MRP in colon cancer and found that while it is present in many tumors, it doesn't help predict how well patients will do.
Methodology
The study used reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry to analyze MRP expression in tumor specimens.
Limitations
The study did not find a relationship between MRP expression and established prognostic factors, which may limit its clinical relevance.
Participant Demographics
Patients with colorectal carcinomas treated at the Surgical Department of the General Hospital of Wiener Neustadt, Austria, between 1988 and 1995.
Want to read the original?
Access the complete publication on the publisher's website